Clinical TrialsSearch results
Number of results: 215
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Cytogenetic features and its clinical implications in Japanese patients with multiple myeloma: retrospective analysis by Japan Myeloma Study Group
- multiple myeloma
- Japan Myeloma Study Group
- 2008-09-22
Other
- Combination therapy of melphalan plus prednisolone and zoledronic acid for untreated multiple myeloma patients ineligible for autologous stem cell transplantation
- Multiple Myeloma
- Myeloma Bone Disease Study Group
- 2008-10-17
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28
Other
- Specimen Aquisition Program and Genetic Analysis for Myelodysplastic Syndromes
- Myelodysplastic Syndromes
- Keio University School of Medicine
- 2007-04-28
Other
- Registration Program for Myelodysplastic Syndromes and Aplastic Anemia
- Myelodysplastic Syndromes Aplastic Anemia
- Keio University School of Medicine
- 2007-04-28
Not yet recruiting
- Expression of genes associated with type 2 inflammation in eosinophilic sinusitis.
- nasal sinus disease
- Kitamura Yoshiaki
- 2023-05-21
Completed
- Evaluation for effectiveness of decrese scattered ray using new radiation protective cover in CT (Computed Tomography)
- no disease specificity
- Higashino Kosaku
- 2020-08-21
Other
- Phase III Randomized Adjuvant Study of Chemotherapy in Node Positive Breast Cancer Patients -AC(Anthracycline-Cyclophosphamide) 4 cycles followed by Taxane 4 cycles (AC-Tac) versus Taxane 8 cycles and Paclitaxel versus Docetaxel-
- node positive breast cancer
- N-SAS BC 02 executive committee
- 2005-08-12
Recruiting
- Effects and safety of narrowband UVB irradiation on gene expression of histamine H1 receptor and allergy-related cytokine in nasal mucosa of healthy subjects: a phase 1 study
- non
- Kitamura Yoshiaki
- 2019-03-14
Other
- Phase II Study of TS-1 with Patient-Reported Outcome(PRO) Evaluation in Elderly Patients with Advanced NSCLC
- Non-small cell lung cancer
- Department of Respiratory Medicine & Rheumatology, Institute of Health Biosciences, The University of Tokushima Graduate School
- 2009-06-29